Plasmodium ovale wallikeri and P. ovale curtisi Infections and Diagnostic Approaches to Imported Malaria, France, 2013-2018.
France
Plasmodium ovale curtisi
Plasmodium ovale wallikeri
diagnosis
imported malaria
malaria
malaria-endemic countries
parasites
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
entrez:
26
1
2021
pubmed:
27
1
2021
medline:
22
6
2021
Statut:
ppublish
Résumé
We retrospectively analyzed epidemiologic, clinical, and biologic characteristics of 368 Plasmodium ovale wallikeri and 309 P. ovale curtisi infections treated in France during January 2013–December 2018. P. ovale wallikeri infections displayed deeper thrombocytopenia and shorter latency periods. Despite similar clinical manifestations, P. ovale wallikeri–infected patients were more frequently treated with artemisinin-based combination therapy. Although the difference was not statistically significant, P. ovale wallikeri–infected patients were 5 times more frequently hospitalized in intensive care or intermediate care and had a higher proportion of severe thrombocytopenia than P. ovale curtisi–infected patients. Rapid diagnostic tests that detect aldolase were more efficient than those detecting Plasmodium lactate dehydrogenase. Sequence analysis of the potra gene from 90 P. ovale isolates reveals an insufficient polymorphism for relapse typing.
Identifiants
pubmed: 33496652
doi: 10.3201/eid2702.202143
pmc: PMC7853592
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Malar J. 2012 Sep 04;11:307
pubmed: 22947418
PLoS One. 2020 Jun 19;15(6):e0235014
pubmed: 32559238
BMJ Open. 2013 May 28;3(5):
pubmed: 23793668
Malar J. 2019 Aug 9;18(1):272
pubmed: 31399031
Am J Trop Med Hyg. 2010 Feb;82(2):235-42
pubmed: 20133999
Malar J. 2013 Sep 13;12:321
pubmed: 24034175
Malar J. 2018 Mar 23;17(1):127
pubmed: 29566685
Sci Rep. 2018 Jan 10;8(1):300
pubmed: 29321578
BMC Med. 2018 Nov 27;16(1):218
pubmed: 30477484
J Infect Dis. 2018 Jun 20;218(2):265-276
pubmed: 29554284
MMWR Surveill Summ. 2019 May 17;68(5):1-35
pubmed: 31099769
J Travel Med. 2001 Mar-Apr;8(2):76-81
pubmed: 11285166
PLoS Med. 2015 Oct 27;12(10):e1001891
pubmed: 26505753
PLoS One. 2012;7(4):e35406
pubmed: 22523591
Malar J. 2018 Oct 30;17(1):399
pubmed: 30376868
Clin Infect Dis. 2019 Nov 27;69(12):2119-2126
pubmed: 31066448
Trends Parasitol. 2015 Jun;31(6):239-45
pubmed: 25816801
J Infect Dis. 2015 Feb 15;211(4):623-34
pubmed: 25170106
Malar J. 2016 Nov 10;15(1):550
pubmed: 27832785
J Clin Microbiol. 2012 Dec;50(12):4100-2
pubmed: 23015675
Genomics. 1996 May 1;33(3):430-44
pubmed: 8661002
Malar J. 2007 Oct 25;6:140
pubmed: 17961215
Malar J. 2018 Feb 9;17(1):78
pubmed: 29426330
Trop Med Int Health. 2014 Sep;19 Suppl 1:7-131
pubmed: 25214480
Microbes Infect. 2002 Jun;4(7):685-92
pubmed: 12067827
PLoS Negl Trop Dis. 2019 Mar 11;13(3):e0007254
pubmed: 30856189
Med Mal Infect. 2020 Mar;50(2):161-193
pubmed: 31964565
Methods Mol Med. 2002;72:189-203
pubmed: 12125116
BMC Infect Dis. 2011 May 23;11:143
pubmed: 21605401
J Infect Dis. 2010 May 15;201(10):1544-50
pubmed: 20380562
Mol Biochem Parasitol. 2002 Jul;122(2):223-6
pubmed: 12106877
Emerg Infect Dis. 2004 Jul;10(7):1235-40
pubmed: 15324543
Adv Parasitol. 2012;80:113-50
pubmed: 23199487
Methods Mol Biol. 2013;1006:247-58
pubmed: 23546796
Crit Care. 2008;12(1):R22
pubmed: 18294371
Malar J. 2012 Aug 24;11:295
pubmed: 22920654
J Clin Microbiol. 2007 May;45(5):1624-7
pubmed: 17360843
Emerg Infect Dis. 2014 Mar;20(3):409-16
pubmed: 24572501
Int J Parasitol. 2011 May;41(6):677-83
pubmed: 21315074
Malar J. 2009 Dec 12;8:293
pubmed: 20003378